Web Simulcast of Major Depressive Disorder: Present State of Clinical Care, Assessing Treatment Challenges

Start Date Sunday, September 6, 2009
End Date Saturday, September 6, 2008
Description This is a live web simulcast of our live symposium Major Depressive Disorder: Present State of Clinical Care, Assessing Treatment Challenges. If you're not able to attend our live symposium in Boston on September 6, register for this web simulcast and listen live to all of the lectures -- with the slides, in real time, right from your desktop, for CME credits. You can listen to the whole day, or pick only the lectures that interest you most. You can log off and log back in during the day as your schedule allows. Plus, you can submit questions online that can be answered by faculty live in Boston. PROGRAM OVERVIEW Mood disorders are common and disabling. Major depressive disorder (MDD) is highly prevalent affecting approximately 14.8 million American adults or about 7% of the general population age 18 and above in any given year. MDD is the leading worldwide cause of disability. Patients with MDD often are under treated or inadequately treated, resulting in continued distress and disability. Depression has been traditionally viewed as a disorder that primarily affects mood and cognition, with only limited somatic correlates such as fatigue and disturbance of sleep and appetite. Recent studies suggest that somatic symptoms are much more central to depressive disorders than initially thought. Somatic presentations of depression are very common in primary care settings and in depressed patients with general medical conditions, and practitioners must be aware that multiple somatic complaints may signal unipolar or bipolar depression. This web simulcast kicks off a comprehensive Psychiatry Academy program on depression: September 6 -- one-day Live Symposium/Web Simulcast September 18 -- one-hour live Webcast September 19 - 30-minute Expert Online Forum September 24 -- one-hour live Webcast September 26 - 30-minute Expert Online Forum
Sponsor Massachusetts General Hospital Psychiatry Academy
Contact Name Glenn Laudenslager
Phone 1 866-644-7792
E-mail mghsupport@reedmeded.com
Website http://www.mghcme.org/?page=events/details&eventid=5189
Format Internet/Website
Location http://www.mghcme.org/?page=events/details&eventid=5189
,
Credit Hours maximum of 6 AMA PRA Category 1 Credit(s)
Credit Category ACCM
Price $40.00
Register by date Saturday, September 6, 2008
Objectives After completing this program, participants should be able to: Demonstrate knowledge regarding the presenting symptoms of depression in primary care and psychiatric settings, and recognize the importance of somatic symptoms in the presentation of depression. Describe the low rates of treatment adherence among patients with mood disorders and utilize methods to increase compliance in this cohort. Recognize the frequency and impact of residual symptoms in mood disorders, and describe interventions to bring patients fully into remission. Formulate a systematic approach to the treatment of depression, and appraise existing evidence regarding the indications, risks, benefits and potential toxicities associated with the use of polypharmacy in the course of depression management. Explore new approaches to treatment that maximizes efficacy and tolerability.